Plasma lecithin: cholesterol acyltransferase in copper-deficient rats

Area of Science:

• Biochemistry
• Nutritional Science
• Cardiovascular Research

Background:

• Individuals at high risk for ischemic heart disease often exhibit low plasma lecithin:cholesterol acyltransferase (LCAT) activity.
• A potential link between copper nutrition and ischemic heart disease risk is hypothesized.

Purpose of the Study:

• To investigate the relationship between copper deficiency and plasma LCAT activity.
• To determine if copper status influences LCAT levels, a factor associated with heart disease risk.

Main Methods:

• Male Sprague-Dawley rats were subjected to copper-deficient diets.
• Copper deficiency was confirmed through biochemical markers: anemia, hypercholesterolemia, and reduced copper levels in kidney and muscle tissue.
• Plasma LCAT activity was measured in copper-deficient and control rats across three experiments.

Main Results:

• Copper-deficient rats exhibited a significant reduction in plasma LCAT activity, ranging from 22% to 32%.
• Anemia, hypercholesterolemia, and low tissue copper concentrations confirmed the copper-deficient state.
• A consistent decrease in LCAT enzyme activity was observed in all experiments involving copper deficiency.

Conclusions:

• Copper deficiency leads to a marked decrease in plasma lecithin:cholesterol acyltransferase activity in rats.
• Copper may play a vital role in the synthesis or structural integrity of LCAT.
• These findings suggest a potential mechanism linking copper nutriture to cardiovascular health via LCAT regulation.